- -

Differential Effects of Adiposity on Pharmacodynamics of Basal Insulins NPH, Glargine, and Detemir in Type 2 Diabetes

RiuNet: Institutional repository of the Polithecnic University of Valencia

Share/Send to

Cited by

Statistics

Differential Effects of Adiposity on Pharmacodynamics of Basal Insulins NPH, Glargine, and Detemir in Type 2 Diabetes

Show full item record

Porcellati, F.; Lucidi, P.; Rossetti, P.; Candeloro, P.; Andreoli, AM.; Marzotti, S.; Cioli, P.... (2011). Differential Effects of Adiposity on Pharmacodynamics of Basal Insulins NPH, Glargine, and Detemir in Type 2 Diabetes. Diabetes Care. 34(12):2521-2523. doi:10.2337/dc11-1064

Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10251/33976

Files in this item

Item Metadata

Title: Differential Effects of Adiposity on Pharmacodynamics of Basal Insulins NPH, Glargine, and Detemir in Type 2 Diabetes
Author: Porcellati, Francesca Lucidi, Paola Rossetti, Paolo Candeloro, Paola Andreoli, Anna Marinelli Marzotti, Stefania Cioli, Patrizia Bolli, Geremia B. Fanelli, Carmine G.
UPV Unit: Universitat Politècnica de València. Instituto Universitario de Automática e Informática Industrial - Institut Universitari d'Automàtica i Informàtica Industrial
Issued date:
Abstract:
[EN] OBJECTIVE-To assess the role of adiposity on the pharmacodynamics of basal insulins NPH, detemir, and glargine in type 2 diabetes mellitus (T2DM), as estimated by glucose infusion rate (GIR) and endogenous glucose ...[+]
Copyrigths: Cerrado
Source:
Diabetes Care. (issn: 0149-5992 )
DOI: 10.2337/dc11-1064
Publisher:
American Diabetes Association
Publisher version: http://dx.doi.org/10.2337/dc11-1064
Thanks:
F.P., P.L., P.R., and C.G.F. received grants from various companies (sanofi-aventis, Eli Lilly, Bristol-Myers Squibb, Novartis, and Merck Sharp & Dohme) for participating at meetings and congresses. G.B.B. received honoraria ...[+]
Type: Artículo

recommendations

 

This item appears in the following Collection(s)

Show full item record